Literature DB >> 16503181

Outcome of bovine herpesvirus 4 infection following direct viral injection in the lateral ventricle of the mouse brain.

Gaetano Donofrio1, Andrea Cavaggioni, Michela Bondi, Sandro Cavirani, Cesidio Filippo Flammini, Carla Mucignat-Caretta.   

Abstract

A recombinant bovine herpesvirus 4 (BoHV-4EGFPDeltaTK), obtained by the insertion of an EGFP gene into the TK locus of DN 599 BoHV-4 strain, was injected into the lateral ventricle of the brain of mice and a clinical score was evaluated for 90 days. Although BoHV-4 was not neuro-pathogenic, BoHV-4EGFPDeltaTK transduction capability was analyzed. EGFP expression was localized in close proximity to the border of the ventricles and EGFP-positive cells were found to co-localize with ependymal cells. Although most of the cells had a polarized morphology, they were not neurons. EGFP-positive cells were seen to spread in tangentially oriented rows within the rostral migratory stream (RMS). Co-localization of EGFP signal with anti-GFAP antibody showed that they were glial cells. EGFP-positive cells were observed until 31 days post-injection and then disappeared completely. Virus isolation was possible at an early post-injection time (3 days), but then virus titer was below the detection limits at later times. Viral DNA, however, could be detected until 21 days post-injection. Thus, in this report we showed that (i) BoHV-4EGFPDeltaTK did not replicate in the mouse brain, (ii) is not pathogenic and (iii) gene transfer can be obtained in long-lived cells belonging to the RMS after BoHV-4EGFPDeltaTK injection within the lateral ventricle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16503181     DOI: 10.1016/j.micinf.2005.10.016

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  15 in total

1.  Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.

Authors:  Gaetano Donofrio; Giulia Tebaldi; Stefania Lanzardo; Roberto Ruiu; Elisabetta Bolli; Andrea Ballatore; Valeria Rolih; Francesca Macchi; Laura Conti; Federica Cavallo
Journal:  Oncoimmunology       Date:  2018-09-06       Impact factor: 8.110

2.  Recombinant bovine herpesvirus 4 (BoHV-4) expressing glycoprotein D of BoHV-1 is immunogenic and elicits serum-neutralizing antibodies against BoHV-1 in a rabbit model.

Authors:  Gaetano Donofrio; Sandro Cavirani; Alain Vanderplasschen; Laurent Gillet; Cesidio Filippo Flammini
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

3.  Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models.

Authors:  Marco Redaelli; Valentina Franceschi; Antonio Capocefalo; Domenico D'Avella; Luca Denaro; Sandro Cavirani; Carla Mucignat-Caretta; Gaetano Donofrio
Journal:  Neuro Oncol       Date:  2012-01-06       Impact factor: 12.300

4.  Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Authors:  Gaetano Donofrio; Valentina Franceschi; Antonio Capocefalo; Simone Taddei; Chiara Sartori; Sabrina Bonomini; Sandro Cavirani; Clotilde S Cabassi; Cesidio F Flammini
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

5.  In vivo image analysis of BoHV-4-based vector in mice.

Authors:  Valentina Franceschi; Fabio Franco Stellari; Carlo Mangia; Sarah Jacca; Sophia Lavrentiadou; Sandro Cavirani; Mathias Heikenwalder; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

6.  Generation and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studies.

Authors:  Valentina Franceschi; Sarah Jacca; Elena L Sassu; Fabio F Stellari; Vicky L van Santen; Gaetano Donofrio
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

7.  Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD.

Authors:  Gaetano Donofrio; Valentina Franceschi; Angela Lovero; Antonio Capocefalo; Michele Camero; Michele Losurdo; Sandro Cavirani; Mariarosaria Marinaro; Erika Grandolfo; Canio Buonavoglia; Maria Tempesta
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Transduction of the rat brain by Bovine Herpesvirus 4.

Authors:  Marco Redaelli; Andrea Cavaggioni; Carla Mucignat-Caretta; Sandro Cavirani; Antonio Caretta; Gaetano Donofrio
Journal:  Genet Vaccines Ther       Date:  2008-02-12

9.  Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.

Authors:  Gaetano Donofrio; Chiara Sartori; Lara Ravanetti; Sandro Cavirani; Laurent Gillet; Alain Vanderplasschen; Simone Taddei; Cesidio Filippo Flammini
Journal:  BMC Biotechnol       Date:  2007-10-18       Impact factor: 2.563

10.  BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-/-) Mice from Monkeypoxvirus Lethal Challenge.

Authors:  Valentina Franceschi; Scott Parker; Sarah Jacca; Ryan W Crump; Konstantin Doronin; Edguardo Hembrador; Daniela Pompilio; Giulia Tebaldi; Ryan D Estep; Scott W Wong; Mark R Buller; Gaetano Donofrio
Journal:  PLoS Negl Trop Dis       Date:  2015-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.